Suchergebnisse - "Mahomed, Sharana"

PubPharm (18)

1

Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women : study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

enthalten in: BMJ open | 2023

von Mahomed, S. | Garrett, N. | Potloane, D. | +24

2

Single-nucleotide polymorphisms in ABC drug transporters alter expression and circulating tenofovir in healthy South African women exposed to pre-exposure prophylaxis

enthalten in: Pharmacogenomics | 2023

von Zondo, N. | Sobia, P. | Sivro, A. | +6

3

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B) : a phase 1, dose-escalation, randomised controlled trial

enthalten in: The lancet. HIV | 2023

von Mahomed, S. | Garrett, N. | Capparelli, E. | +18

CommentIn: Lancet HIV. 2023 Apr;10(4):e211-e212. - PMID 37001961

4

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention

enthalten in: The Journal of infectious diseases | 2022

von Mahomed, S. | Garrett, N. | Capparelli, E. | +19

5

Women for science and science for women : Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention

enthalten in: Frontiers in immunology | 2022

von Karim, Q. | Archary, D. | Barré-Sinoussi, F. | +15

6

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

enthalten in: The New England journal of medicine | 2021

von Corey, L. | Gilbert, P. | Juraska, M. | +143

CommentIn: N Engl J Med. 2021 Mar 18;384(11):1068-1069. - PMID 33730459

7

Clinical Trials of Broadly Neutralizing Monoclonal Antibodies for Human Immunodeficiency Virus Prevention : A Review

enthalten in: The Journal of infectious diseases | 2021

von Mahomed, S. | Garrett, N. | Baxter, C. | +2

8

Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women : study protocol for the first-in-human CAPRISA 012B phase I clinical trial

enthalten in: BMJ open | 2020

von Mahomed, S. | Garrett, N. | Karim, Q. | +18

9

Discordant line probe genotypic testing vs culture-based drug susceptibility phenotypic testing in TB endemic KwaZulu-Natal : Impact on bedside clinical decision making

enthalten in: Journal of clinical tuberculosis and other mycobacterial diseases | 2020

von Mahomed, S. | Mlisana, K. | Cele, L. | +1

10

Assessing the safety and pharmacokinetics of the monoclonal antibodies, VRC07-523LS and PGT121 in HIV negative women in South Africa : study protocol for the CAPRISA 012A randomised controlled phase I trial

enthalten in: BMJ open | 2019

von Mahomed, S. | Garrett, N. | Capparelli, E. | +11